Market News (Page 2) - TendieTensor

Market News Page 2 of 282 • 7,046 articles

Gold, Silver Spike To Record Highs As Fed Independence Falters: What's Moving Markets Monday?

Benzinga • Piero Cingari

Gold, Silver Spike To Record Highs As Fed Independence Falters: What's Moving Markets Monday?

01/12/2026 12:43 PM • Gold and silver surged to record highs Monday as investors reassessed Federal Reserve independence concerns following a DOJ criminal probe into Fed Chair Jerome Powell. The move sparked a rotation from Treasuries into precious metals. Financial stocks underperformed after Trump proposed capping credit card rates at 10%, while energy and tech stocks gained. Major indices showed modest gains ahead of inflation data and earnings season.

TMUSI - Mentioned as a parent company/advertising solutions provider with no specific action or performance highlighted
COF - Stock tumbled 6.6% following Trump's proposal to cap credit card interest rates at 10%, posting worst session since April 2025

#Federal Reserve independence #gold prices #silver prices #DOJ investigation #credit card interest rates #financial stocks #earnings season #inflation data

Aedifica NV/SA: Publication relating to a transparency notification

GlobeNewswire Inc. • Na

Aedifica NV/SA: Publication relating to a transparency notification

01/12/2026 12:00 PM • Aedifica, a Belgian public regulated real estate company listed on Euronext Brussels and Amsterdam, has published a transparency notification regarding a shareholding disclosure from BlackRock, Inc.

BLK - The notification merely reports BlackRock's shareholding in Aedifica as required by transparency regulations. This is a factual disclosure with no indication of strategic intent or market impact.

#transparency notification #shareholding disclosure #BlackRock #Aedifica #real estate company

Pfizer Cancer Combo Drug Shows Strong Tumor Shrinkage in Colorectal Cancer Trial

Benzinga • Vandana Singh

Pfizer Cancer Combo Drug Shows Strong Tumor Shrinkage in Colorectal Cancer Trial

01/12/2026 11:58 AM • Pfizer announced positive Phase 3 BREAKWATER trial data showing its Braftovi combination therapy (with cetuximab and FOLFIRI) demonstrated a 64.4% confirmed objective response rate in BRAF V600E-mutant metastatic colorectal cancer patients, significantly outperforming standard-of-care treatment (39.2%). The drug received accelerated FDA approval in December 2024, with continued approval contingent on verification of clinical benefit.

MDAIW - The company was featured prominently at a medical conference, received positive quotes from medical professionals, and was recognized on TIME's list of Top HealthTech companies, indicating strong technological and market potential
PFE - Pfizer's Braftovi combination therapy demonstrated clinically meaningful and statistically significant improvements in tumor response rates (64.4% vs 39.2%) compared to standard treatment, with 57.4% of patients achieving responses lasting 6+ months. This strong efficacy data supports the drug's accelerated FDA approval and validates the treatment approach for BRAF V600E-mutant colorectal cancer.

#Braftovi #encorafenib #colorectal cancer #BREAKWATER trial #BRAF V600E-mutant #objective response rate #FDA approval #cetuximab #metastatic colorectal cancer

Khaby Lame's TikTok Army Fuels Rich Sparkle's $4 Billion Sales Vision

Benzinga • Akanksha Bakshi

Khaby Lame's TikTok Army Fuels Rich Sparkle's $4 Billion Sales Vision

01/12/2026 11:57 AM • Rich Sparkle Holdings (NASDAQ: ANPA) completed its acquisition of Step Distinctive Limited, linked to TikTok star Khaby Lame, to leverage his 360 million followers for live-commerce sales. The company projects fan-driven sales could reach $4 billion annually through exclusive partnerships, AI-powered digital twins, and expansion across the US, Middle East, and Southeast Asia.

ANPA - The company completed a strategic acquisition to monetize a massive creator following (360M), projects significant revenue potential ($4B annually), and is implementing innovative AI digital twin technology for scalability. Stock trading above both 50-day and 200-day moving averages indicates strong technical momentum.

#acquisition #TikTok #live-commerce #digital twin #AI #creator economy #e-commerce #influencer marketing

Is Netflix a Buy Ahead of Earnings? It Looks Like It

Investing.com • Sam Quirke

Is Netflix a Buy Ahead of Earnings? It Looks Like It

01/12/2026 11:54 AM • Netflix stock has fallen 30% from all-time highs due to missed earnings, uncertainty around the Warner Bros. Discovery acquisition, and rising debt concerns. However, technical indicators suggest oversold conditions with RSI at 29 and a bullish MACD crossover. The stock trades at its lowest P/E ratio in years, and analysts from Morgan Stanley and Wolfe Research maintain Buy ratings with $120 price targets, suggesting significant upside from current $90 levels. The article argues much of the downside is already priced in ahead of the upcoming earnings report.

NFLX - Despite recent 30% decline from highs and October earnings miss, technical indicators show oversold conditions (RSI 29, bullish MACD crossover), valuation is at multi-year lows, and multiple analysts maintain Buy ratings with $120 price targets implying 33% upside from $90. Strong historical track record of beating expectations and much of negative sentiment already priced in ahead of earnings.

#Netflix earnings #stock valuation #technical analysis #oversold conditions #Warner Bros. Discovery acquisition #analyst ratings #buy opportunity

American Express Sells Off as Markets Price Policy Risk Ahead of Details

Investing.com • Timothy Fries

American Express Sells Off as Markets Price Policy Risk Ahead of Details

01/12/2026 11:43 AM • American Express and other financial stocks tumbled following President Trump's announcement of a proposed 10% cap on credit card interest rates. AXP fell 5.03% to $356.75, while major banks and consumer finance companies experienced broader selloffs. Analysts warn the cap would severely hurt revenue and profits for credit card issuers, potentially forcing them to raise fees and reduce credit availability.

MA - Involved in joint venture for crypto-to-fiat payment card
AXP - Stock fell 5.03% following Trump's credit card interest rate cap announcement. Two-day loss exceeded 6%. While company has strong long-term performance, near-term prospects are uncertain due to regulatory risk.

#credit card interest rate cap #financial sector selloff #regulatory risk #Trump policy announcement #consumer finance impact

The Motley Fool • Jeremy Bowman

Why Upstart Stock Lost 29% in 2025

01/12/2026 11:34 AM • Upstart Holdings stock declined 29% in 2025 despite strong business fundamentals, including 79% revenue growth and a return to profitability through the first three quarters. The decline was driven by market concerns about rising credit risk, a weakening labor market, and increased auto loan delinquencies. While the company's AI models have held up and the business is stronger than in 2022, credit market fears overshadowed positive earnings results.

UPST - Stock fell 29% in 2025 due to market concerns about rising credit risk and weakening labor market conditions, despite strong underlying business growth (79% revenue increase) and return to profitability. The disconnect between fundamentals and stock performance reflects investor fears about future credit deterioration.

#fintech #AI model #credit risk #loan origination #labor market #auto delinquencies #profitability #volatility

Non-Woven Filter Media Market Size to Reach USD 14.32 Billion by 2033 Due to the Rising Need for Quality Filtration Solutions in Different Industries | SNS Insider

GlobeNewswire Inc. • Sns Insider

Non-Woven Filter Media Market Size to Reach USD 14.32 Billion by 2033 Due to the Rising Need for Quality Filtration Solutions in Different Industries | SNS Insider

01/12/2026 11:00 AM • The global non-woven filter media market is projected to grow from USD 8.54 billion in 2025 to USD 14.32 billion by 2033, with a CAGR of 6.70%. Growth is driven by increasing demand for high-efficiency filtration solutions across healthcare, HVAC, and industrial sectors, with Asia-Pacific leading at 45% of global production. Spunbond technology dominates with 38.60% market share, while meltblown and nano-fiber filters show fastest growth. Recent developments include Freudenberg Group's new product launch and the Berry Global-Glatfelter merger forming Magnera Corp.

WST - Specializes in injectable drug packaging and delivery systems, showing strategic focus in a growing market segment
KMB - Listed as major player in expanding non-woven filter media market with strong demand from healthcare sector, which leads with 31.50% market share.

#non-woven filter media #filtration solutions #market growth #healthcare #HVAC systems #air filtration #water treatment #Asia-Pacific #spunbond technology #meltblown

Endpoint Security Market Projected to Reach US$ 65.04 Billion by 2035 Amid Rising Cyber Threat Activity | Astute Analytica

GlobeNewswire Inc. • Astute Analytica

Endpoint Security Market Projected to Reach US$ 65.04 Billion by 2035 Amid Rising Cyber Threat Activity | Astute Analytica

01/12/2026 11:00 AM • The global endpoint security market is expected to grow from USD 21.90 billion in 2025 to USD 65.04 billion by 2035 at a CAGR of 11.5%, driven by escalating cyber threats (161 billion annually), workforce shortages, and enterprise adoption of AI-driven autonomous platforms and unified XDR solutions. Software solutions dominate with over 60% market share through subscription models, while large enterprises account for 65% of revenue due to regulatory compliance mandates.

CRWD - Highlighted as a market leader consolidating share through platformization; 64% of customers subscribe to 5+ modules; serves 29,000+ subscription customers with strong ARR growth

#endpoint security #cybersecurity #XDR platforms #AI-driven security #data breach costs #platformization #managed detection and response #zero-day vulnerabilities #cloud security #IoT security

$1.55 Bn Disease Registry Software Global Markets, 2019-2024, 2024-2029F, 2034F: Shift to Value-based Care and Addressing Rare Diseases Offer Further Growth Avenues

GlobeNewswire Inc. • Researchandmarkets.Com

$1.55 Bn Disease Registry Software Global Markets, 2019-2024, 2024-2029F, 2034F: Shift to Value-based Care and Addressing Rare Diseases Offer Further Growth Avenues

01/12/2026 11:00 AM • The disease registry software market is experiencing robust growth, expanding from $1.39 billion in 2024 to $1.55 billion in 2025 with an 11.2% CAGR through 2029. Growth drivers include rising chronic disease burden, increased clinical research, EHR adoption, and the shift toward value-based care and personalized medicine. Key developments include Health Catalyst's acquisition of Electronic Registry Systems and the launch of digital registries like the CONNECT-HCM Registry.

UNH - Listed as a leading market player in the growing disease registry software sector, positioned to benefit from market expansion projected at 11.2% CAGR through 2029.

#disease registry software #healthcare IT #personalized medicine #value-based care #electronic health records #clinical research #rare diseases #precision medicine #telehealth integration

Planet Labs Shares Jump Following 9-Figure Deal With Sweden

Benzinga • Dylan Berman

Planet Labs Shares Jump Following 9-Figure Deal With Sweden

01/12/2026 10:54 AM • Planet Labs announced a multi-year nine-figure satellite services agreement with Sweden's Armed Forces, marking its third major satellite services contract in 12 months. The company has now signed over $500 million in satellite services contracts in the past year, including deals with Japan and Germany. Planet Labs shares jumped approximately 6.69% on the news.

DD - Supplies critical materials like Tyvek® for sterile medical packaging applications
PL - The company secured a significant nine-figure multi-year contract with Sweden, representing its third major satellite services deal in 12 months. This demonstrates strong market demand for its services, validates its business model, and contributed to a 6.69% stock price increase. The cumulative $500 million in contracts over the past year signals sustained growth and confidence from government customers.

#satellite services #Sweden Armed Forces #space-based data #government contracts #national security #multi-year agreement #space technology

$15+ Bn Equipment Management Software Markets, 2019-2024, 2024-2029F, 2034F: Growth Driven by Mobile-based Tracking and AI-driven Analytics, Along with a Strong Emphasis on Industry 4.0 Initiatives

GlobeNewswire Inc. • Researchandmarkets.Com

$15+ Bn Equipment Management Software Markets, 2019-2024, 2024-2029F, 2034F: Growth Driven by Mobile-based Tracking and AI-driven Analytics, Along with a Strong Emphasis on Industry 4.0 Initiatives

01/12/2026 10:53 AM • The equipment management software market is experiencing robust growth, expanding from $9.52 billion in 2024 to a projected $15.06 billion by 2029 at a 9.5% CAGR. Growth is driven by cloud-based solutions, AI-driven analytics, mobile tracking technologies, and Industry 4.0 initiatives. North America currently dominates the market while Asia-Pacific shows the fastest growth trajectory.

GRRMY - Offers diverse packaging solutions including primary packaging and contract packaging services
MSFT - Listed as a major industry player pioneering AI-driven predictive analytics and IoT-enabled monitoring in the growing equipment management software market.

#equipment management software #cloud-based solutions #AI-driven analytics #Industry 4.0 #predictive maintenance #digital transformation #asset management #IoT monitoring

$3.44 Bn Quantum-Safe Software-Defined Wide Area Network (SD-WAN) Solution Markets, 2019-2024, 2024-2029F, 2034F - Innovations in AI, Quantum Cryptography, and Zero-trust Architectures

GlobeNewswire Inc. • Researchandmarkets.Com

$3.44 Bn Quantum-Safe Software-Defined Wide Area Network (SD-WAN) Solution Markets, 2019-2024, 2024-2029F, 2034F - Innovations in AI, Quantum Cryptography, and Zero-trust Architectures

01/12/2026 10:51 AM • The global quantum-safe SD-WAN market is experiencing rapid growth, expanding from $1.0 billion in 2024 to $1.28 billion in 2025, with projections reaching $3.44 billion by 2029 at a 28% CAGR. Growth is driven by increasing demand for secure networking solutions, quantum-resistant encryption adoption, cloud infrastructure expansion, and zero-trust architecture implementations. Key industry players are making strategic moves, including Fortinet's post-quantum cryptography updates and HPE's $13.4 billion acquisition of Juniper Networks to strengthen their secure, AI-driven networking capabilities.

CSCO - Listed as a leading market player in the rapidly growing quantum-safe SD-WAN sector, positioned to benefit from the 28% CAGR market expansion through 2029.

#quantum-safe SD-WAN #quantum cryptography #zero-trust architecture #secure networking #cloud infrastructure #post-quantum cryptography #network security #AI-driven network management

Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026

Benzinga • Prnewswire

Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026

01/12/2026 10:35 AM • The oncology landscape is experiencing rapid regulatory advancement as precision medicine and genomics expand significantly. Multiple biotech companies are advancing cancer therapies toward accelerated FDA approvals in 2026, with the precision medicine market projected to grow from $138.67 billion in 2026 to $537.17 billion by 2035. Key developments include Oncolytics' pelareorep showing strong response rates in anal cancer, CG Oncology's Phase 3 trial ahead of schedule, Zentalis advancing azenosertib in ovarian cancer, ArriVent initiating a pivotal Phase 3 study for firmonertinib, and PDS Biotechnology gaining FDA alignment on trial endpoints.

BNTX - Mentioned as previous employer of the newly appointed CTO
ONCY - Pelareorep demonstrated strong clinical efficacy with 29% objective response rate in third-line anal cancer (vs. historical 10% or less) and 30% in second-line setting. Planning registration-directed study with FDA Type C meeting in Q1 2026, positioning for potential accelerated approval in an unmet medical need indication.

#accelerated approval #oncology #precision medicine #immunotherapy #cancer treatment #FDA #clinical trials #biotech #drug development

Why Kratos Defense Stock Keeps Going Up Today

The Motley Fool • Rich Smith

Why Kratos Defense Stock Keeps Going Up Today

01/12/2026 10:30 AM • Kratos Defense stock rose 3.31% on January 12, 2026, as the company announced plans to build a new 40,000 square foot factory in Birmingham, Alabama to expand weapons production. The move aligns with President Trump's new defense policy calling for a $1.5 trillion defense budget expansion, contingent on defense contractors committing capital investments rather than dividends or buybacks. However, the analyst notes concerns about the stock's extremely high valuation at 800 times trailing earnings and lack of free cash flow.

KTOS - Stock gained 3.31% on announcement of new factory expansion aligned with Trump's defense spending priorities. Company is positioning itself favorably for increased defense contracts and government spending. However, sentiment is tempered by significant valuation concerns (800x trailing earnings) and lack of free cash flow.

#defense contractors #weapons production #Trump defense policy #capital investment #military drones #valuation concerns

Murphy USA CEO Sells $1.7 Million in Stock -- Here's What Investors Should Know

The Motley Fool • Jonathan Ponciano

Murphy USA CEO Sells $1.7 Million in Stock -- Here's What Investors Should Know

01/12/2026 10:30 AM • Murphy USA's President & CEO Malynda K West sold 4,051 shares worth approximately $1.7 million on January 7 through a net exercise of stock options. The transaction was executed under a pre-established Rule 10b5-1 plan adopted in August, indicating administrative rather than opportunistic timing. Despite the sale reducing direct holdings to 117,388 shares, West maintains a substantial $50 million stake. The company continues to demonstrate strong operational performance with robust cash flow, merchandise growth, and aggressive capital returns through stock buybacks and dividend increases.

BTMWW - Company is expanding its network, entering new retail locations, and showing growth momentum with strategic partnerships
MUSA - While the CEO's stock sale might appear negative on the surface, the article emphasizes that the transaction was pre-planned and administrative in nature under a Rule 10b5-1 plan. The CEO maintains substantial holdings ($50M), and the company demonstrates strong fundamentals with solid cash flow, merchandise growth, and consistent shareholder returns through buybacks and dividend increases. The sale does not indicate loss of confidence in the company.

#insider selling #stock options #net exercise #CEO stock sale #capital allocation #shareholder returns #Rule 10b5-1 plan

Wandering Buffalo Opens in Downtown Bozeman

GlobeNewswire Inc. • Unknown

Wandering Buffalo Opens in Downtown Bozeman

01/12/2026 10:00 AM • Wandering Buffalo Hotel and Lodge, a newly redesigned 38-room boutique hotel, has opened on East Main Street in downtown Bozeman, Montana. The property features modern amenities, locally sourced offerings, and serves as a basecamp for outdoor adventures and local exploration. The hotel is affiliated with World of Hyatt's Mr. & Mrs. Smith collection and the Stash Hotel Rewards program.

H - Wandering Buffalo Hotel's membership in World of Hyatt's Mr. & Mrs. Smith collection represents portfolio expansion and diversification into distinctive independent hotels, demonstrating Hyatt's strategy to capture the boutique hotel market segment.

#boutique hotel #Bozeman Montana #hospitality #outdoor tourism #hotel opening #World of Hyatt #downtown development

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

GlobeNewswire Inc. • Nvidia Corporation

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

01/12/2026 10:00 AM • NVIDIA announced a major expansion of its BioNeMo platform for AI-driven drug discovery, including new models for RNA structure prediction and drug synthesis. The company launched landmark collaborations with Eli Lilly on a co-innovation lab with up to $1 billion investment over five years, and with Thermo Fisher to build autonomous lab infrastructure. A growing ecosystem of biotech companies are adopting BioNeMo for AI-driven molecular design and drug discovery.

GSK - Acquiring rights to relaunch BREXAFEMME with potential market opportunity
NVDA - NVIDIA is expanding its BioNeMo platform with new capabilities, securing major partnerships with leading pharmaceutical and life sciences companies, and positioning itself as the central AI infrastructure provider for drug discovery. The $1 billion Lilly investment and Thermo Fisher collaboration demonstrate strong market validation and revenue growth potential.

#AI drug discovery #BioNeMo platform #autonomous laboratories #pharmaceutical innovation #accelerated computing #molecular design #foundation models #lab automation

Ditch the Resolutions, Keep the Savings: Denny’s Launches NEW Slammin’ Meal Deals Starting at $5.99

GlobeNewswire Inc. • Denny'S Media Team

Ditch the Resolutions, Keep the Savings: Denny’s Launches NEW Slammin’ Meal Deals Starting at $5.99

01/12/2026 10:00 AM • Denny's launched a new Slammin' Meal Deals value menu starting at $5.99 featuring full breakfast, lunch, and dinner meals, along with the return of guest-favorite Salted Caramel Banana Slams and new Mocha Cold Brew options. The campaign targets 'Quitter's Day' (January 12) when New Year's resolutions typically fail, positioning comfort food and value as alternatives to restrictive dieting.

DENN - The company is launching strategic menu innovations with a new value-focused offering at an attractive price point ($5.99), bringing back popular items, and expanding beverage options. The campaign demonstrates marketing agility by capitalizing on a cultural moment (Quitter's Day) and emphasizes value and customer rewards, which should drive traffic and customer retention during a traditionally weak period for restaurants.

#value menu #Quitter's Day #Salted Caramel Banana Slams #comfort food #family dining #Denny's Rewards #cold brew #meal deals

Black Rock Coffee Bar Continues Expansion in Colorado with New Colorado Springs Location

GlobeNewswire Inc. • Not Specified

Black Rock Coffee Bar Continues Expansion in Colorado with New Colorado Springs Location

01/12/2026 10:00 AM • Black Rock Coffee Bar, an Oregon-based boutique coffee company, is opening its third location in Colorado Springs on January 16, 2026. The expansion marks the beginning of the company's planned growth in the region throughout 2026. The new store will offer opening week specials and features the brand's specialty coffees, teas, smoothies, and Fuel energy drinks.

BRCB - The company is actively expanding its footprint with a new location marking its third in Colorado Springs, demonstrating business growth and market confidence. CEO commentary expresses optimism about future expansion plans in 2026, and the company reports positive community reception. The introduction of new menu items and loyalty program features indicates ongoing innovation and customer engagement initiatives.

#expansion #Colorado Springs #new location #coffee shop #opening week specials #Fuel energy drinks #Black Rock Rewards

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

GlobeNewswire Inc. • Na

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

01/12/2026 10:00 AM • NVIDIA and Eli Lilly announced a first-of-its-kind AI co-innovation lab to accelerate drug discovery and pharmaceutical manufacturing. The companies will invest up to $1 billion over five years in the San Francisco Bay Area facility, combining Lilly's pharmaceutical expertise with NVIDIA's AI and computing capabilities. The lab will focus on creating continuous learning systems connecting wet labs with computational resources, using NVIDIA's BioNeMo platform and Vera Rubin architecture to build advanced AI models for drug development.

NVDA - NVIDIA is positioned as a key technology partner providing critical AI infrastructure, computing platforms (BioNeMo, Vera Rubin), and expertise. The partnership validates NVIDIA's AI leadership in life sciences and expands its addressable market in pharmaceutical R&D, representing significant business opportunity and strategic positioning.

#AI co-innovation lab #drug discovery #pharmaceutical manufacturing #BioNeMo platform #foundation models #digital twins #robotics #accelerated computing

Global Utility Poles Market Set to Reach US$ 71.31 Billion by 2033 | Astute Analytica

GlobeNewswire Inc. • Astute Analytica

Global Utility Poles Market Set to Reach US$ 71.31 Billion by 2033 | Astute Analytica

01/12/2026 10:00 AM • The global utility poles market is projected to grow from US$ 47.45 billion in 2024 to US$ 71.31 billion by 2033 at a CAGR of 4.63%, driven by grid modernization, smart grid integration, and telecom expansion. Distribution poles command 47.4% market share, while energy transmission and distribution account for 79.4% of revenue. Europe is leading investments with major TSOs like TenneT and Elia Group committing billions to renewable energy integration and cross-border connectivity.

TECK - Referenced as having a past-producing mine near the exploration site, no direct operational impact
VMI - Listed as a key company in the utility poles market which is experiencing significant growth with projected CAGR of 4.63% through 2033, driven by grid modernization and infrastructure expansion.

#utility poles market #grid modernization #smart poles #5G infrastructure #renewable energy integration #distribution infrastructure #transmission poles #composite materials

What to Know About a $356,000 Perpetua Insider Stock Sale Amid a 145% Price Surge

The Motley Fool • Jonathan Ponciano

What to Know About a $356,000 Perpetua Insider Stock Sale Amid a 145% Price Surge

01/12/2026 09:33 AM • A director at Perpetua Resources sold 13,148 shares worth $356,192 on January 5-7, representing 44.57% of direct holdings. This was the director's first open-market sale following a 145% stock price surge over the past year. The sale stemmed from exercising options and likely reflects personal portfolio management rather than loss of conviction, as the company recently broke ground on its Stibnite Gold Project and secured over $380 million in equity financing.

PPTA - While the insider sale could signal profit-taking, the article emphasizes this is likely routine portfolio management from option exercise rather than a loss of confidence. The company's recent achievements (project groundbreaking, $380M+ financing, potential $2B debt financing) and transition to execution phase suggest positive fundamentals. The 145% price surge and strong capital position offset concerns about the insider sale.

#insider stock sale #option exercise #mineral exploration #gold mining #antimony #Stibnite Gold Project #equity financing #critical minerals

Will Quantum Computing Stocks Become the AI Stocks of 2026?

The Motley Fool • Adria Cimino

Will Quantum Computing Stocks Become the AI Stocks of 2026?

01/12/2026 09:32 AM • The article explores whether quantum computing stocks could drive market gains similar to AI stocks in 2026. While quantum computing pure plays like Rigetti Computing, D-Wave Quantum, and IonQ have surged significantly, the author concludes it's too early for quantum stocks to match AI's market impact, as quantum computing remains in earlier development stages compared to AI's current revenue-generating phase. However, progress in quantum computing could still benefit these stocks and related tech giants long-term.

RGTI - Stock has surged in quadruple digits over three years, but author notes it's too early for quantum stocks to drive overall market gains like AI stocks have done. Potential exists but remains speculative.

#quantum computing #AI stocks #market growth #technology investment #quantum computing stocks #pure play companies

Court Ruling Ends Edwards Lifesciences $1.2 Billion Plan To Acquire JenaValve

Benzinga • Vandana Singh

Court Ruling Ends Edwards Lifesciences $1.2 Billion Plan To Acquire JenaValve

01/12/2026 09:31 AM • A U.S. District Court granted the FTC's motion to block Edwards Lifesciences' $1.2 billion acquisition of JenaValve Technology, citing concerns that the deal would eliminate competition in the TAVR-AR device market and potentially harm innovation and patient access. Despite the setback, Edwards raised its 2026 adjusted EPS guidance to $2.90-$3.05 and continues advancing its own transcatheter aortic regurgitation valve.

BIVIW - Company is advancing multiple late-stage clinical programs with promising drug candidates targeting significant medical conditions, showing strong safety data and potential for market expansion
EW - The company faced a significant setback with the blocked acquisition, which is negative. However, this was offset by raised 2026 EPS guidance and continued progress on its own SOJOURN transcatheter valve program, resulting in a neutral overall sentiment.

#acquisition blocked #FTC injunction #TAVR-AR devices #medical devices #competition #transcatheter valves #aortic regurgitation